Publications by authors named "Ethan Strattan"

Claim this Profile
R
Role of Defibrotide in the Prevention of Murine Model Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
Senthilnathan Palaniyandi, Reena Kumari, Ethan Strattan, Timothy Huang, Katharina Kohler

Transplant Cell Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial inhibition of Tec kinases BTK and ITK is beneficial in ameliorating murine sclerodermatous chronic graft versus host disease.
Senthilnathan Palaniyandi, Ethan Strattan, Reena Kumari, Miranda Mysinger, Natalya Hakim

Bone Marrow Transplant· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mast Cell Involvement in Fibrosis in Chronic Graft-Versus-Host Disease.
Ethan Strattan, Gerhard Carl Hildebrandt

Int J Mol Sci· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiome: an emerging new frontier in graft‑versus‑host disease.
Reena Kumari, Senthilnathan Palaniyandi, Ethan Strattan, Gerhard C Hildebrandt

Inflamm Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prolyl Hydroxylase Inhibitor Dimethyl Oxalyl Glycine Decreases Early Gastrointestinal GVHD in Experimental Allogeneic Hematopoietic Cell Transplantation.
Senthilnathan Palaniyandi, Reena Kumari, Sabarinath Venniyil Radhakrishnan, Ethan Strattan, Natalya Hakim

Transplantation· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mast Cells Are Mediators of Fibrosis and Effector Cell Recruitment in Dermal Chronic Graft-vs.-Host Disease.
Ethan Strattan, Senthilnathan Palaniyandi, Reena Kumari, Jing Du, Natalya Hakim

Front Immunol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNFAIP8 Deficiency Exacerbates Acute Graft Versus Host Disease in a Murine Model of Allogeneic Hematopoietic Cell Transplantation.
Reena Kumari, Senthilnathan Palaniyandi, Ethan Strattan, Timothy Huang, Katharina Kohler

Transplantation· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The α4β7 blockade with vedolizumab is effective in prevention of graft vs. host disease using a xenogeneic mouse model.
Senthilnathan Palaniyandi, Reena Kumari, Ethan Strattan, Timothy Huang, Jing Du

Am J Hematol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia.
Emily M McWilliams, Jennifer M Mele, Carolyn Cheney, Elizabeth A Timmerman, Faraz Fiazuddin, Ethan J Strattan

Oncoimmunology· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation.
Ta-Ming Liu, Jennifer A Woyach, Yiming Zhong, Arletta Lozanski, Gerard Lozanski, Ethan Strattan

Blood· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694.
Yiming Zhong, Shuai Dong, Ethan Strattan, Li Ren, Jonathan P Butchar

J Biol Chem· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis